Condition
Left Ventricular (LV) Systolic Dysfunction clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Left Ventricular (LV) Systolic Dysfunction clinical trials that are recruiting, at sites in 5 countries (most in Bosnia and Herzegovina (1), Serbia (1), Taiwan (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 5Countries
Newest Left Ventricular (LV) Systolic Dysfunction clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| AI-guided ECG screening to target guideline heart-failure medications and prevent left ventricular dysfunction | — | Taipei, Taipei | Recruiting | Jan 21, 2026 |
| Using a new cardiac device to treat heart failure with less invasive techniques | — | Banja Luka, Republic of Srbska and 3 other locations | Recruiting | Apr 9, 2025 |
| Predicting heart function using echocardiography and body composition data | — | Yongin, Gyeonggi-do | Recruiting | Feb 6, 2025 |
| Hybrid ablation for treating persistent atrial fibrillation | — | Chertsey and 6 other locations | Recruiting | Jun 9, 2022 |
All recruiting trials (4)
-
AI-guided ECG screening to target guideline heart-failure medications and prevent left ventricular dysfunction
This project tests whether an AI-read ECG can find people with normal ejection fraction who are at high risk of future left ventricular dysfunction and whether starting guideline-directed heart-failure medicines can lower that risk.
-
Using a new cardiac device to treat heart failure with less invasive techniques
This study is testing a new heart device that can be implanted with less invasive methods to see if it helps people with heart failure feel better and improve heart function.
-
Predicting heart function using echocardiography and body composition data
This study is testing if combining heart ultrasound results with body composition data can help predict heart function in people with and without heart failure.
-
Hybrid ablation for treating persistent atrial fibrillation
This study is testing a new hybrid treatment for people with persistent atrial fibrillation to see if it works better than the standard catheter procedure in helping them stay free from heart rhythm problems.
Related topics
Quick answers
How many Left Ventricular (LV) Systolic Dysfunction clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in Bosnia and Herzegovina (1 trial), Serbia (1 trial), Taiwan (1 trial), United Kingdom (1 trial), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.